{"entities": [{"EntityRegistrantName": "ABBOTT LABORATORIES", "TradingSymbol": "ABT", "EntityCentralIndexKey": "1800", "db": 1, "Industry_SEC": "Pharmaceutical Preparations", "Industry_SEC_db": 2834, "Industry": "Pharmaceutical", "Industry_db": 37, "Region": "Illinois", "Region_db": 14, "SecurityExchangeName": "0", "SECurl": "0", "URL": "", "SEC_Update": "2021-11-11", "SEC_UpdateDateAndTime": null, "SecuritiesUpdate": "2021-06-02T00:00:00Z", "OpinionLastYear": null, "OpinionSecondLastYear": null, "OpinionThirdLastYear": null, "OpinionFourthLastYear": null, "ClockLastYear": 98.0, "ClockSecondLastYear": 206.0, "ClockThirdLastYear": 209.0, "ClockFourthLastYear": 136.0, "BridgeLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeSecondLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeThirdLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeFourthLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "Anomalies": "0", "AnomaliesRatio1": 95.21, "AnomaliesRatio2": 81.65, "AnomaliesRatio3": 89.05, "AnomaliesRatio4": 97.11, "AnomaliesRatio5": 142.06, "AnomaliesRatio6": 62.41, "NumberOfYearsAudited": 0, "CommonSharesIntrinsicValueLastYear": 185712609375, "CommonSharesIntrinsicValueSecondLastYear": 315318285714, "CommonSharesIntrinsicValueThirdLastYear": 264929523810, "CommonSharesIntrinsicValueFourthLastYear": 135746523426, "MarketCapitalizationLastYear": 189376488370, "MarketCapitalizationSecondLastYear": 153171811487, "MarketCapitalizationThirdLastYear": 127045494557, "MarketCapitalizationFourthLastYear": 99663275216, "CommonShareIntrinsicValueLastYear": 104.83, "CommonShareIntrinsicValueSecondLastYear": 178.81, "CommonShareIntrinsicValueThirdLastYear": 150.83, "CommonShareIntrinsicValueFourthLastYear": 77.73, "CommonSharePriceLastYear": 106.9, "CommonSharePriceSecondLastYear": 86.86, "CommonSharePriceThirdLastYear": 72.33, "CommonSharePriceFourthLastYear": 57.07, "CommonSharesOutstandingLastYear": 1771529358, "CommonSharesOutstandingSecondLastYear": 1763433243, "CommonSharesOutstandingThirdLastYear": 1756470269, "CommonSharesOutstandingFourthLastYear": 1746333892, "month_end": 12, "lastyear": "2020-12-31", "secondlastyear": "2019-12-31", "thirdlastyear": "2018-12-31", "fourthlastyear": "2017-12-31", "fifthlastyear": "2016-12-31", "sixthlastyear": "2015-12-31", "amendlastyear": "", "amendsecondlastyear": "", "amendthirdlastyear": "", "amendfourthlastyear": "", "amendfifthlastyear": "", "amendsixthlastyear": "", "accessionnumberlastyear": "0001104659-21-025751", "accessionnumbersecondlastyear": "0001104659-20-023904", "accessionnumberthirdlastyear": "0001047469-19-000624", "accessionnumberfourthlastyear": "0001047469-18-000856", "accessionnumberfifthlastyear": "0001047469-17-000744", "accessionnumbersixthlastyear": "0001047469-16-010246", "urlbalancesheetlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/R6.htm", "urlbalancesheetsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/R6.htm", "urlbalancesheetthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/R6.htm", "urlbalancesheetfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746918000856/R6.htm", "urlbalancesheetfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746917000744/R6.htm", "urlbalancesheetsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/R6.htm", "urlincomestatementlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/R2.htm", "urlincomestatementsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/R2.htm", "urlincomestatementthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/R2.htm", "urlincomestatementfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746918000856/R2.htm", "urlincomestatementfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746917000744/R2.htm", "urlincomestatementsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/R2.htm", "urlcomprehensiveincomelastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/R3.htm", "urlcomprehensiveincomesecondlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/R3.htm", "urlcomprehensiveincomethirdlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/R3.htm", "urlcomprehensiveincomefourthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746918000856/R3.htm", "urlcomprehensiveincomefifthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746917000744/R3.htm", "urlcomprehensiveincomesixthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/R3.htm", "urlshareholdersequitylastyear": "", "urlshareholdersequitysecondlastyear": "", "urlshareholdersequitythirdlastyear": "", "urlshareholdersequityfourthlastyear": "", "urlshareholdersequityfifthlastyear": "", "urlshareholdersequitysixthlastyear": "", "urlcashflowlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/R5.htm", "urlcashflowsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/R5.htm", "urlcashflowthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/R5.htm", "urlcashflowfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746918000856/R5.htm", "urlcashflowfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746917000744/R5.htm", "urlcashflowsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/R5.htm", "ad1.db": 0, "ad1.AccessionNumber": "0001104659-21-025751", "ad1.AmendmentFlag": "", "ad1.EntityRegistrantName": "ABBOTT LABORATORIES", "ad1.Period": "lastyear", "ad1.PeriodEndDate": "2020-12-31", "ad1.TradingSymbol": "ABT", "ad1.CurrentAssets": 20441000000, "ad1.NonCurrentAssets": 52107000000, "ad1.Assets": 0, "ad1.CurrentLiabilities": -11907000000, "ad1.NonCurrentLiabilities": -60641000000, "ad1.Liabilities": 0, "ad1.ShareholdersEquity": 0, "ad1.LiabilitiesAndShareholdersEquity": 0, "ad1.CurrentAssetsGL_i": "", "ad1.CurrentAssetsGL_ii": "", "ad1.CurrentAssetsGL_iii": "", "ad1.AnomalyCurrentAssets": -1867000000, "ad1.AnomalyCurrentAssetsSEC": 0, "ad1.NonCurrentAssetsGL_i": "", "ad1.NonCurrentAssetsGL_ii": "", "ad1.NonCurrentAssetsGL_iii": "", "ad1.AnomalyNonCurrentAssets": -16898000000, "ad1.AnomalyNonCurrentAssetsSEC": 0, "ad1.AnomalyAssets": 0, "ad1.CurrentLiabilitiesGL_i": "", "ad1.CurrentLiabilitiesGL_ii": "", "ad1.CurrentLiabilitiesGL_iii": "", "ad1.AnomalyCurrentLiabilities": 0, "ad1.AnomalyCurrentLiabilitiesSEC": 0, "ad1.NonCurrentLiabilitiesGL_i": "", "ad1.NonCurrentLiabilitiesGL_ii": "", "ad1.NonCurrentLiabilitiesGL_iii": "", "ad1.AnomalyNonCurrentLiabilities": -33003000000, "ad1.AnomalyNonCurrentLiabilitiesSEC": 0, "ad1.AnomalyLiabilities": 0, "ad1.AnomalyShareholdersEquity": -219000000, "ad1.ShareholdersEquityBalanceGL_i": "", "ad1.ShareholdersEquityBalanceGL_ii": "", "ad1.ShareholdersEquityBalanceGL_iii": "", "ad1.AnomalyShareholdersEquitySEC": 0, "ad1.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad1.Sales": 0, "ad1.CostOfSales": 0, "ad1.GrossMargin": -19605000000, "ad1.OperatingExpenses": 0, "ad1.OperatingIncome": -5357000000, "ad1.IncomeBeforeTaxes": -4968000000, "ad1.NetIncome": -2500000, "ad1.NetIncomeAttributableToNonControllingInterest": 0, "ad1.GrossMarginGL_i": "", "ad1.GrossMarginGL_ii": "", "ad1.GrossMarginGL_iii": "", "ad1.AnomalyGrossMargin": 0, "ad1.OperatingExpensesGL_i": "", "ad1.OperatingExpensesGL_ii": "", "ad1.OperatingExpensesGL_iii": "", "ad1.AnomalyOperatingExpenses": 0, "ad1.OperatingIncomeGL_i": "", "ad1.OperatingIncomeGL_ii": "", "ad1.OperatingIncomeGL_iii": "", "ad1.AnomalyOperatingIncome": 0, "ad1.IncomeBeforeTaxesGL_i": "", "ad1.IncomeBeforeTaxesGL_ii": "", "ad1.IncomeBeforeTaxesGL_iii": "", "ad1.AnomalyIncomeBeforeTaxes": 0, "ad1.NetIncomeGL_i": "", "ad1.NetIncomeGL_ii": "", "ad1.NetIncomeGL_iii": "", "ad1.AnomalyNetIncome": -4989500000, "ad1.OtherComprehensiveIncome": 150000000, "ad1.ComprehensiveIncome": 0, "ad1.OtherComprehensiveIncomeGL_i": "", "ad1.OtherComprehensiveIncomeGL_ii": "", "ad1.OtherComprehensiveIncomeGL_iii": "", "ad1.AnomalyOtherComprehensiveIncome": 4161500000, "ad1.AnomalyComprehensiveIncome": 0, "ad1.ShareholdersEquityBeginning": 0, "ad1.ConvertibleDebt": 0, "ad1.CommonShares": 0, "ad1.PreferredShares": 0, "ad1.RetainedEarnings": 0, "ad1.AccumulatedOtherComprehensiveIncome": 0, "ad1.TreasuryShares": 0, "ad1.EmployeeBenefitTrust": 0, "ad1.NonControllingInterests": 0, "ad1.AnomalyConvertibleDebt": 0, "ad1.AnomalyCommonShares": 0, "ad1.AnomalyPreferredShares": 0, "ad1.AnomalyRetainedEarnings": 0, "ad1.AnomalyAccumulatedOtherComprehensiveIncome": -4161500000, "ad1.AnomalyTreasuryShares": 0, "ad1.AnomalyEmployeeBenefitTrust": 0, "ad1.AnomalyNonControllingInterests": 0, "ad1.ShareholdersEquityGL_i": "", "ad1.ShareholdersEquityGL_ii": "", "ad1.ShareholdersEquityGL_iii": "", "ad1.OperatingActivities": 0, "ad1.InvestingActivities": 0, "ad1.FinancingActivities": 0, "ad1.IncreaseDecreaseInCash": 0, "ad1.CashFlowCashExplainedDifference": 0, "ad1.OperatingActivitiesGL_i": "", "ad1.OperatingActivitiesGL_ii": "", "ad1.OperatingActivitiesGL_iii": "", "ad1.AnomalyOperatingActivities": 0, "ad1.AnomalyOperatingActivitiesSEC": 0, "ad1.InvestingActivitiesGL_i": "", "ad1.InvestingActivitiesGL_ii": "", "ad1.InvestingActivitiesGL_iii": "", "ad1.AnomalyInvestingActivities": -58000000, "ad1.AnomalyInvestingActivitiesSEC": 0, "ad1.FinancingActivitiesGL_i": "", "ad1.FinancingActivitiesGL_ii": "", "ad1.FinancingActivitiesGL_iii": "", "ad1.AnomalyFinancingActivities": 0, "ad1.AnomalyFinancingActivitiesSEC": 0, "ad1.TargetWorkingCapital": 1.2, "ad1.ReinvestmentOfMaintenance": 0, "ad1.NormalizedDividendPaymentToNonControllingInterests": 0, "ad1.NormalizedDividendPaymentToPreferredShareholders": 0, "ad1.TheoricalInterestRate": 0.035, "ad1.TheoricalTaxRate": 0.15, "ad1.CapitalizationRateFloor": 0.021, "ad2.db": 0, "ad2.AccessionNumber": "0001104659-20-023904", "ad2.AmendmentFlag": "", "ad2.EntityRegistrantName": "ABBOTT LABORATORIES", "ad2.Period": "secondlastyear", "ad2.PeriodEndDate": "2019-12-31", "ad2.TradingSymbol": "ABT", "ad2.CurrentAssets": 15667000000, "ad2.NonCurrentAssets": 52220000000, "ad2.Assets": 0, "ad2.CurrentLiabilities": -10863000000, "ad2.NonCurrentLiabilities": -57024000000, "ad2.Liabilities": 0, "ad2.ShareholdersEquity": 0, "ad2.LiabilitiesAndShareholdersEquity": 0, "ad2.CurrentAssetsGL_i": "", "ad2.CurrentAssetsGL_ii": "", "ad2.CurrentAssetsGL_iii": "", "ad2.AnomalyCurrentAssets": -1786000000, "ad2.AnomalyCurrentAssetsSEC": 0, "ad2.NonCurrentAssetsGL_i": "", "ad2.NonCurrentAssetsGL_ii": "", "ad2.NonCurrentAssetsGL_iii": "", "ad2.AnomalyNonCurrentAssets": -15170000000, "ad2.AnomalyNonCurrentAssetsSEC": 0, "ad2.AnomalyAssets": 0, "ad2.CurrentLiabilitiesGL_i": "", "ad2.CurrentLiabilitiesGL_ii": "", "ad2.CurrentLiabilitiesGL_iii": "", "ad2.AnomalyCurrentLiabilities": 0, "ad2.AnomalyCurrentLiabilitiesSEC": 0, "ad2.NonCurrentLiabilitiesGL_i": "", "ad2.NonCurrentLiabilitiesGL_ii": "", "ad2.NonCurrentLiabilitiesGL_iii": "", "ad2.AnomalyNonCurrentLiabilities": -31301000000, "ad2.AnomalyNonCurrentLiabilitiesSEC": 0, "ad2.AnomalyLiabilities": 0, "ad2.AnomalyShareholdersEquity": -213000000, "ad2.ShareholdersEquityBalanceGL_i": "", "ad2.ShareholdersEquityBalanceGL_ii": "", "ad2.ShareholdersEquityBalanceGL_iii": "", "ad2.AnomalyShareholdersEquitySEC": 0, "ad2.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad2.Sales": 0, "ad2.CostOfSales": 0, "ad2.GrossMargin": -18673000000, "ad2.OperatingExpenses": 0, "ad2.OperatingIncome": -4532000000, "ad2.IncomeBeforeTaxes": -4077000000, "ad2.NetIncome": -3687000000, "ad2.NetIncomeAttributableToNonControllingInterest": 0, "ad2.GrossMarginGL_i": "", "ad2.GrossMarginGL_ii": "", "ad2.GrossMarginGL_iii": "", "ad2.AnomalyGrossMargin": 0, "ad2.OperatingExpensesGL_i": "", "ad2.OperatingExpensesGL_ii": "", "ad2.OperatingExpensesGL_iii": "", "ad2.AnomalyOperatingExpenses": 0, "ad2.OperatingIncomeGL_i": "", "ad2.OperatingIncomeGL_ii": "", "ad2.OperatingIncomeGL_iii": "", "ad2.AnomalyOperatingIncome": 0, "ad2.IncomeBeforeTaxesGL_i": "", "ad2.IncomeBeforeTaxesGL_ii": "", "ad2.IncomeBeforeTaxesGL_iii": "", "ad2.AnomalyIncomeBeforeTaxes": 0, "ad2.NetIncomeGL_i": "", "ad2.NetIncomeGL_ii": "", "ad2.NetIncomeGL_iii": "", "ad2.AnomalyNetIncome": -390000000, "ad2.OtherComprehensiveIncome": 4925000000, "ad2.ComprehensiveIncome": 0, "ad2.OtherComprehensiveIncomeGL_i": "", "ad2.OtherComprehensiveIncomeGL_ii": "", "ad2.OtherComprehensiveIncomeGL_iii": "", "ad2.AnomalyOtherComprehensiveIncome": 1238000000, "ad2.AnomalyComprehensiveIncome": 0, "ad2.ShareholdersEquityBeginning": 0, "ad2.ConvertibleDebt": 0, "ad2.CommonShares": 0, "ad2.PreferredShares": 0, "ad2.RetainedEarnings": 0, "ad2.AccumulatedOtherComprehensiveIncome": 0, "ad2.TreasuryShares": 0, "ad2.EmployeeBenefitTrust": 0, "ad2.NonControllingInterests": 0, "ad2.AnomalyConvertibleDebt": 0, "ad2.AnomalyCommonShares": 0, "ad2.AnomalyPreferredShares": 0, "ad2.AnomalyRetainedEarnings": 0, "ad2.AnomalyAccumulatedOtherComprehensiveIncome": -1238000000, "ad2.AnomalyTreasuryShares": 0, "ad2.AnomalyEmployeeBenefitTrust": 0, "ad2.AnomalyNonControllingInterests": 0, "ad2.ShareholdersEquityGL_i": "", "ad2.ShareholdersEquityGL_ii": "", "ad2.ShareholdersEquityGL_iii": "", "ad2.OperatingActivities": 0, "ad2.InvestingActivities": 0, "ad2.FinancingActivities": 0, "ad2.IncreaseDecreaseInCash": 0, "ad2.CashFlowCashExplainedDifference": 0, "ad2.OperatingActivitiesGL_i": "", "ad2.OperatingActivitiesGL_ii": "", "ad2.OperatingActivitiesGL_iii": "", "ad2.AnomalyOperatingActivities": 0, "ad2.AnomalyOperatingActivitiesSEC": 0, "ad2.InvestingActivitiesGL_i": "", "ad2.InvestingActivitiesGL_ii": "", "ad2.InvestingActivitiesGL_iii": "", "ad2.AnomalyInvestingActivities": -48000000, "ad2.AnomalyInvestingActivitiesSEC": 0, "ad2.FinancingActivitiesGL_i": "", "ad2.FinancingActivitiesGL_ii": "", "ad2.FinancingActivitiesGL_iii": "", "ad2.AnomalyFinancingActivities": 0, "ad2.AnomalyFinancingActivitiesSEC": 0, "ad2.TargetWorkingCapital": 1.2, "ad2.ReinvestmentOfMaintenance": 0, "ad2.NormalizedDividendPaymentToNonControllingInterests": 0, "ad2.NormalizedDividendPaymentToPreferredShareholders": 0, "ad2.TheoricalInterestRate": 0.035, "ad2.TheoricalTaxRate": 0.15, "ad2.CapitalizationRateFloor": 0.021, "ad3.db": 0, "ad3.AccessionNumber": "0001047469-19-000624", "ad3.AmendmentFlag": "", "ad3.EntityRegistrantName": "ABBOTT LABORATORIES", "ad3.Period": "thirdlastyear", "ad3.PeriodEndDate": "2018-12-31", "ad3.TradingSymbol": "ABT", "ad3.CurrentAssets": 14641000000, "ad3.NonCurrentAssets": 17000000, "ad3.Assets": 0, "ad3.CurrentLiabilities": -9012000000, "ad3.NonCurrentLiabilities": -58161000000, "ad3.Liabilities": 0, "ad3.ShareholdersEquity": 0, "ad3.LiabilitiesAndShareholdersEquity": 0, "ad3.CurrentAssetsGL_i": "", "ad3.CurrentAssetsGL_ii": "", "ad3.CurrentAssetsGL_iii": "", "ad3.AnomalyCurrentAssets": -1577000000, "ad3.AnomalyCurrentAssetsSEC": 0, "ad3.NonCurrentAssetsGL_i": "", "ad3.NonCurrentAssetsGL_ii": "", "ad3.NonCurrentAssetsGL_iii": "", "ad3.AnomalyNonCurrentAssets": -14311000000, "ad3.AnomalyNonCurrentAssetsSEC": 0, "ad3.AnomalyAssets": 0, "ad3.CurrentLiabilitiesGL_i": "", "ad3.CurrentLiabilitiesGL_ii": "", "ad3.CurrentLiabilitiesGL_iii": "", "ad3.AnomalyCurrentLiabilities": 0, "ad3.AnomalyCurrentLiabilitiesSEC": 0, "ad3.NonCurrentLiabilitiesGL_i": "", "ad3.NonCurrentLiabilitiesGL_ii": "", "ad3.NonCurrentLiabilitiesGL_iii": "", "ad3.AnomalyNonCurrentLiabilities": -30722000000, "ad3.AnomalyNonCurrentLiabilitiesSEC": 0, "ad3.AnomalyLiabilities": 0, "ad3.AnomalyShareholdersEquity": -198000000, "ad3.ShareholdersEquityBalanceGL_i": "", "ad3.ShareholdersEquityBalanceGL_ii": "", "ad3.ShareholdersEquityBalanceGL_iii": "", "ad3.AnomalyShareholdersEquitySEC": 0, "ad3.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad3.Sales": 0, "ad3.CostOfSales": 0, "ad3.GrossMargin": -17872000000, "ad3.OperatingExpenses": 0, "ad3.OperatingIncome": -3650000000, "ad3.IncomeBeforeTaxes": -2873000000, "ad3.NetIncome": -2368000000, "ad3.NetIncomeAttributableToNonControllingInterest": 0, "ad3.GrossMarginGL_i": "", "ad3.GrossMarginGL_ii": "", "ad3.GrossMarginGL_iii": "", "ad3.AnomalyGrossMargin": 0, "ad3.OperatingExpensesGL_i": "", "ad3.OperatingExpensesGL_ii": "", "ad3.OperatingExpensesGL_iii": "", "ad3.AnomalyOperatingExpenses": 0, "ad3.OperatingIncomeGL_i": "", "ad3.OperatingIncomeGL_ii": "", "ad3.OperatingIncomeGL_iii": "", "ad3.AnomalyOperatingIncome": 0, "ad3.IncomeBeforeTaxesGL_i": "", "ad3.IncomeBeforeTaxesGL_ii": "", "ad3.IncomeBeforeTaxesGL_iii": "", "ad3.AnomalyIncomeBeforeTaxes": 0, "ad3.NetIncomeGL_i": "", "ad3.NetIncomeGL_ii": "", "ad3.NetIncomeGL_iii": "", "ad3.AnomalyNetIncome": -573000000, "ad3.OtherComprehensiveIncome": 4860000000, "ad3.ComprehensiveIncome": 0, "ad3.OtherComprehensiveIncomeGL_i": "", "ad3.OtherComprehensiveIncomeGL_ii": "", "ad3.OtherComprehensiveIncomeGL_iii": "", "ad3.AnomalyOtherComprehensiveIncome": 2492000000, "ad3.AnomalyComprehensiveIncome": 0, "ad3.ShareholdersEquityBeginning": 0, "ad3.ConvertibleDebt": 0, "ad3.CommonShares": 0, "ad3.PreferredShares": 0, "ad3.RetainedEarnings": 0, "ad3.AccumulatedOtherComprehensiveIncome": 0, "ad3.TreasuryShares": 0, "ad3.EmployeeBenefitTrust": 0, "ad3.NonControllingInterests": 0, "ad3.AnomalyConvertibleDebt": 0, "ad3.AnomalyCommonShares": 0, "ad3.AnomalyPreferredShares": 0, "ad3.AnomalyRetainedEarnings": 0, "ad3.AnomalyAccumulatedOtherComprehensiveIncome": -2492000000, "ad3.AnomalyTreasuryShares": 0, "ad3.AnomalyEmployeeBenefitTrust": 0, "ad3.AnomalyNonControllingInterests": 0, "ad3.ShareholdersEquityGL_i": "", "ad3.ShareholdersEquityGL_ii": "", "ad3.ShareholdersEquityGL_iii": "", "ad3.OperatingActivities": 0, "ad3.InvestingActivities": 0, "ad3.FinancingActivities": 0, "ad3.IncreaseDecreaseInCash": 0, "ad3.CashFlowCashExplainedDifference": 0, "ad3.OperatingActivitiesGL_i": "", "ad3.OperatingActivitiesGL_ii": "", "ad3.OperatingActivitiesGL_iii": "", "ad3.AnomalyOperatingActivities": 0, "ad3.AnomalyOperatingActivitiesSEC": 0, "ad3.InvestingActivitiesGL_i": "", "ad3.InvestingActivitiesGL_ii": "", "ad3.InvestingActivitiesGL_iii": "", "ad3.AnomalyInvestingActivities": -48000000, "ad3.AnomalyInvestingActivitiesSEC": 0, "ad3.FinancingActivitiesGL_i": "", "ad3.FinancingActivitiesGL_ii": "", "ad3.FinancingActivitiesGL_iii": "", "ad3.AnomalyFinancingActivities": 0, "ad3.AnomalyFinancingActivitiesSEC": 0, "ad3.TargetWorkingCapital": 1.2, "ad3.ReinvestmentOfMaintenance": 0, "ad3.NormalizedDividendPaymentToNonControllingInterests": 0, "ad3.NormalizedDividendPaymentToPreferredShareholders": 0, "ad3.TheoricalInterestRate": 0.035, "ad3.TheoricalTaxRate": 0.15, "ad3.CapitalizationRateFloor": 0.021, "ad4.db": 0, "ad4.AccessionNumber": "0001047469-18-000856", "ad4.AmendmentFlag": "", "ad4.EntityRegistrantName": "ABBOTT LABORATORIES", "ad4.Period": "fourthlastyear", "ad4.PeriodEndDate": "2017-12-31", "ad4.TradingSymbol": "ABT", "ad4.CurrentAssets": 20167000000, "ad4.NonCurrentAssets": 176000000, "ad4.Assets": 0, "ad4.CurrentLiabilities": -8912000000, "ad4.NonCurrentLiabilities": -67338000000, "ad4.Liabilities": 0, "ad4.ShareholdersEquity": 0, "ad4.LiabilitiesAndShareholdersEquity": 0, "ad4.CurrentAssetsGL_i": "", "ad4.CurrentAssetsGL_ii": "", "ad4.CurrentAssetsGL_iii": "", "ad4.AnomalyCurrentAssets": -1707000000, "ad4.AnomalyCurrentAssetsSEC": 0, "ad4.NonCurrentAssetsGL_i": "", "ad4.NonCurrentAssetsGL_ii": "", "ad4.NonCurrentAssetsGL_iii": "", "ad4.AnomalyNonCurrentAssets": -14007000000, "ad4.AnomalyNonCurrentAssetsSEC": 0, "ad4.AnomalyAssets": 0, "ad4.CurrentLiabilitiesGL_i": "", "ad4.CurrentLiabilitiesGL_ii": "", "ad4.CurrentLiabilitiesGL_iii": "", "ad4.AnomalyCurrentLiabilities": 0, "ad4.AnomalyCurrentLiabilitiesSEC": 0, "ad4.NonCurrentLiabilitiesGL_i": "", "ad4.NonCurrentLiabilitiesGL_ii": "", "ad4.NonCurrentLiabilitiesGL_iii": "", "ad4.AnomalyNonCurrentLiabilities": -31098000000, "ad4.AnomalyNonCurrentLiabilitiesSEC": 0, "ad4.AnomalyLiabilities": 0, "ad4.AnomalyShareholdersEquity": -201000000, "ad4.ShareholdersEquityBalanceGL_i": "", "ad4.ShareholdersEquityBalanceGL_ii": "", "ad4.ShareholdersEquityBalanceGL_iii": "", "ad4.AnomalyShareholdersEquitySEC": 0, "ad4.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad4.Sales": 0, "ad4.CostOfSales": 0, "ad4.GrossMargin": -15053000000, "ad4.OperatingExpenses": 0, "ad4.OperatingIncome": -1726000000, "ad4.IncomeBeforeTaxes": -2231000000, "ad4.NetIncome": -477000000, "ad4.NetIncomeAttributableToNonControllingInterest": 0, "ad4.GrossMarginGL_i": "", "ad4.GrossMarginGL_ii": "", "ad4.GrossMarginGL_iii": "", "ad4.AnomalyGrossMargin": 0, "ad4.OperatingExpensesGL_i": "", "ad4.OperatingExpensesGL_ii": "", "ad4.OperatingExpensesGL_iii": "", "ad4.AnomalyOperatingExpenses": 0, "ad4.OperatingIncomeGL_i": "", "ad4.OperatingIncomeGL_ii": "", "ad4.OperatingIncomeGL_iii": "", "ad4.AnomalyOperatingIncome": 0, "ad4.IncomeBeforeTaxesGL_i": "", "ad4.IncomeBeforeTaxesGL_ii": "", "ad4.IncomeBeforeTaxesGL_iii": "", "ad4.AnomalyIncomeBeforeTaxes": 0, "ad4.NetIncomeGL_i": "", "ad4.NetIncomeGL_ii": "", "ad4.NetIncomeGL_iii": "", "ad4.AnomalyNetIncome": -2002000000, "ad4.OtherComprehensiveIncome": 3536000000, "ad4.ComprehensiveIncome": 0, "ad4.OtherComprehensiveIncomeGL_i": "", "ad4.OtherComprehensiveIncomeGL_ii": "", "ad4.OtherComprehensiveIncomeGL_iii": "", "ad4.AnomalyOtherComprehensiveIncome": 3059000000, "ad4.AnomalyComprehensiveIncome": 0, "ad4.ShareholdersEquityBeginning": 0, "ad4.ConvertibleDebt": 0, "ad4.CommonShares": 0, "ad4.PreferredShares": 0, "ad4.RetainedEarnings": 0, "ad4.AccumulatedOtherComprehensiveIncome": 0, "ad4.TreasuryShares": 0, "ad4.EmployeeBenefitTrust": 0, "ad4.NonControllingInterests": 0, "ad4.AnomalyConvertibleDebt": 0, "ad4.AnomalyCommonShares": 0, "ad4.AnomalyPreferredShares": 0, "ad4.AnomalyRetainedEarnings": 0, "ad4.AnomalyAccumulatedOtherComprehensiveIncome": -3059000000, "ad4.AnomalyTreasuryShares": 0, "ad4.AnomalyEmployeeBenefitTrust": 0, "ad4.AnomalyNonControllingInterests": 0, "ad4.ShareholdersEquityGL_i": "", "ad4.ShareholdersEquityGL_ii": "", "ad4.ShareholdersEquityGL_iii": "", "ad4.OperatingActivities": 0, "ad4.InvestingActivities": 0, "ad4.FinancingActivities": 0, "ad4.IncreaseDecreaseInCash": 0, "ad4.CashFlowCashExplainedDifference": 0, "ad4.OperatingActivitiesGL_i": "", "ad4.OperatingActivitiesGL_ii": "", "ad4.OperatingActivitiesGL_iii": "", "ad4.AnomalyOperatingActivities": 0, "ad4.AnomalyOperatingActivitiesSEC": 0, "ad4.InvestingActivitiesGL_i": "", "ad4.InvestingActivitiesGL_ii": "", "ad4.InvestingActivitiesGL_iii": "", "ad4.AnomalyInvestingActivities": -8746000000, "ad4.AnomalyInvestingActivitiesSEC": 0, "ad4.FinancingActivitiesGL_i": "", "ad4.FinancingActivitiesGL_ii": "", "ad4.FinancingActivitiesGL_iii": "", "ad4.AnomalyFinancingActivities": 710000000, "ad4.AnomalyFinancingActivitiesSEC": 0, "ad4.TargetWorkingCapital": 1.2, "ad4.ReinvestmentOfMaintenance": 0, "ad4.NormalizedDividendPaymentToNonControllingInterests": 0, "ad4.NormalizedDividendPaymentToPreferredShareholders": 0, "ad4.TheoricalInterestRate": 0.035, "ad4.TheoricalTaxRate": 0.15, "ad4.CapitalizationRateFloor": 0.021, "ad5.db": 0, "ad5.AccessionNumber": "0001047469-17-000744", "ad5.AmendmentFlag": "", "ad5.EntityRegistrantName": "ABBOTT LABORATORIES", "ad5.Period": "fifthlastyear", "ad5.PeriodEndDate": "2016-12-31", "ad5.TradingSymbol": "ABT", "ad5.CurrentAssets": 27289000000, "ad5.NonCurrentAssets": 2753000000, "ad5.Assets": 0, "ad5.CurrentLiabilities": -6905000000, "ad5.NonCurrentLiabilities": -59000000, "ad5.Liabilities": 0, "ad5.ShareholdersEquity": -45702000000, "ad5.LiabilitiesAndShareholdersEquity": 0, "ad5.CurrentAssetsGL_i": "", "ad5.CurrentAssetsGL_ii": "", "ad5.CurrentAssetsGL_iii": "", "ad5.AnomalyCurrentAssets": -2832000000, "ad5.AnomalyCurrentAssetsSEC": 0, "ad5.NonCurrentAssetsGL_i": "", "ad5.NonCurrentAssetsGL_ii": "", "ad5.NonCurrentAssetsGL_iii": "", "ad5.AnomalyNonCurrentAssets": -10996000000, "ad5.AnomalyNonCurrentAssetsSEC": 0, "ad5.AnomalyAssets": 0, "ad5.CurrentLiabilitiesGL_i": "", "ad5.CurrentLiabilitiesGL_ii": "", "ad5.CurrentLiabilitiesGL_iii": "", "ad5.AnomalyCurrentLiabilities": -490000000, "ad5.AnomalyCurrentLiabilitiesSEC": 0, "ad5.NonCurrentLiabilitiesGL_i": "", "ad5.NonCurrentLiabilitiesGL_ii": "", "ad5.NonCurrentLiabilitiesGL_iii": "", "ad5.AnomalyNonCurrentLiabilities": 25171000000, "ad5.AnomalyNonCurrentLiabilitiesSEC": 0, "ad5.AnomalyLiabilities": 0, "ad5.AnomalyShareholdersEquity": 45523000000, "ad5.ShareholdersEquityBalanceGL_i": "", "ad5.ShareholdersEquityBalanceGL_ii": "", "ad5.ShareholdersEquityBalanceGL_iii": "", "ad5.AnomalyShareholdersEquitySEC": 0, "ad5.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad5.Sales": 0, "ad5.CostOfSales": 0, "ad5.GrossMargin": -11829000000, "ad5.OperatingExpenses": 0, "ad5.OperatingIncome": -3185000000, "ad5.IncomeBeforeTaxes": -1413000000, "ad5.NetIncome": -1400000000, "ad5.NetIncomeAttributableToNonControllingInterest": 0, "ad5.GrossMarginGL_i": "", "ad5.GrossMarginGL_ii": "", "ad5.GrossMarginGL_iii": "", "ad5.AnomalyGrossMargin": 0, "ad5.OperatingExpensesGL_i": "", "ad5.OperatingExpensesGL_ii": "", "ad5.OperatingExpensesGL_iii": "", "ad5.AnomalyOperatingExpenses": 0, "ad5.OperatingIncomeGL_i": "", "ad5.OperatingIncomeGL_ii": "", "ad5.OperatingIncomeGL_iii": "", "ad5.AnomalyOperatingIncome": 0, "ad5.IncomeBeforeTaxesGL_i": "", "ad5.IncomeBeforeTaxesGL_ii": "", "ad5.IncomeBeforeTaxesGL_iii": "", "ad5.AnomalyIncomeBeforeTaxes": 0, "ad5.NetIncomeGL_i": "", "ad5.NetIncomeGL_ii": "", "ad5.NetIncomeGL_iii": "", "ad5.AnomalyNetIncome": -687000000, "ad5.OtherComprehensiveIncome": 4910000000, "ad5.ComprehensiveIncome": 0, "ad5.OtherComprehensiveIncomeGL_i": "", "ad5.OtherComprehensiveIncomeGL_ii": "", "ad5.OtherComprehensiveIncomeGL_iii": "", "ad5.AnomalyOtherComprehensiveIncome": 3510000000, "ad5.AnomalyComprehensiveIncome": 0, "ad5.ShareholdersEquityBeginning": 0, "ad5.ConvertibleDebt": 0, "ad5.CommonShares": 0, "ad5.PreferredShares": 0, "ad5.RetainedEarnings": 0, "ad5.AccumulatedOtherComprehensiveIncome": 0, "ad5.TreasuryShares": 0, "ad5.EmployeeBenefitTrust": 0, "ad5.NonControllingInterests": 0, "ad5.AnomalyConvertibleDebt": 0, "ad5.AnomalyCommonShares": 0, "ad5.AnomalyPreferredShares": 0, "ad5.AnomalyRetainedEarnings": 0, "ad5.AnomalyAccumulatedOtherComprehensiveIncome": -3510000000, "ad5.AnomalyTreasuryShares": 0, "ad5.AnomalyEmployeeBenefitTrust": 0, "ad5.AnomalyNonControllingInterests": 0, "ad5.ShareholdersEquityGL_i": "", "ad5.ShareholdersEquityGL_ii": "", "ad5.ShareholdersEquityGL_iii": "", "ad5.OperatingActivities": 0, "ad5.InvestingActivities": 0, "ad5.FinancingActivities": 0, "ad5.IncreaseDecreaseInCash": 0, "ad5.CashFlowCashExplainedDifference": 0, "ad5.OperatingActivitiesGL_i": "", "ad5.OperatingActivitiesGL_ii": "", "ad5.OperatingActivitiesGL_iii": "", "ad5.AnomalyOperatingActivities": 0, "ad5.AnomalyOperatingActivitiesSEC": 0, "ad5.InvestingActivitiesGL_i": "", "ad5.InvestingActivitiesGL_ii": "", "ad5.InvestingActivitiesGL_iii": "", "ad5.AnomalyInvestingActivities": -25000000, "ad5.AnomalyInvestingActivitiesSEC": 0, "ad5.FinancingActivitiesGL_i": "", "ad5.FinancingActivitiesGL_ii": "", "ad5.FinancingActivitiesGL_iii": "", "ad5.AnomalyFinancingActivities": -78000000, "ad5.AnomalyFinancingActivitiesSEC": 0, "ad5.TargetWorkingCapital": 1.2, "ad5.ReinvestmentOfMaintenance": 0, "ad5.NormalizedDividendPaymentToNonControllingInterests": 0, "ad5.NormalizedDividendPaymentToPreferredShareholders": 0, "ad5.TheoricalInterestRate": 0.035, "ad5.TheoricalTaxRate": 0.15, "ad5.CapitalizationRateFloor": 0.021, "ad6.db": 0, "ad6.AccessionNumber": "0001047469-16-010246", "ad6.AmendmentFlag": "", "ad6.EntityRegistrantName": "ABBOTT LABORATORIES", "ad6.Period": "sixthlastyear", "ad6.PeriodEndDate": "2015-12-31", "ad6.TradingSymbol": "ABT", "ad6.CurrentAssets": 14260000000, "ad6.NonCurrentAssets": 2000000, "ad6.Assets": 0, "ad6.CurrentLiabilities": -9559000000, "ad6.NonCurrentLiabilities": -31688000000, "ad6.Liabilities": 0, "ad6.ShareholdersEquity": 0, "ad6.LiabilitiesAndShareholdersEquity": 0, "ad6.CurrentAssetsGL_i": "", "ad6.CurrentAssetsGL_ii": "", "ad6.CurrentAssetsGL_iii": "", "ad6.AnomalyCurrentAssets": -2118000000, "ad6.AnomalyCurrentAssetsSEC": 0, "ad6.NonCurrentAssetsGL_i": "", "ad6.NonCurrentAssetsGL_ii": "", "ad6.NonCurrentAssetsGL_iii": "", "ad6.AnomalyNonCurrentAssets": -11023000000, "ad6.AnomalyNonCurrentAssetsSEC": 0, "ad6.AnomalyAssets": 0, "ad6.CurrentLiabilitiesGL_i": "", "ad6.CurrentLiabilitiesGL_ii": "", "ad6.CurrentLiabilitiesGL_iii": "", "ad6.AnomalyCurrentLiabilities": -746000000, "ad6.AnomalyCurrentLiabilitiesSEC": 0, "ad6.NonCurrentLiabilitiesGL_i": "", "ad6.NonCurrentLiabilitiesGL_ii": "", "ad6.NonCurrentLiabilitiesGL_iii": "", "ad6.AnomalyNonCurrentLiabilities": -20953000000, "ad6.AnomalyNonCurrentLiabilitiesSEC": 0, "ad6.AnomalyLiabilities": 0, "ad6.AnomalyShareholdersEquity": -115000000, "ad6.ShareholdersEquityBalanceGL_i": "", "ad6.ShareholdersEquityBalanceGL_ii": "", "ad6.ShareholdersEquityBalanceGL_iii": "", "ad6.AnomalyShareholdersEquitySEC": 0, "ad6.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad6.Sales": 0, "ad6.CostOfSales": 0, "ad6.GrossMargin": -11658000000, "ad6.OperatingExpenses": 0, "ad6.OperatingIncome": -2867000000, "ad6.IncomeBeforeTaxes": -3183000000, "ad6.NetIncome": -4423000000, "ad6.NetIncomeAttributableToNonControllingInterest": 0, "ad6.GrossMarginGL_i": "", "ad6.GrossMarginGL_ii": "", "ad6.GrossMarginGL_iii": "", "ad6.AnomalyGrossMargin": 0, "ad6.OperatingExpensesGL_i": "", "ad6.OperatingExpensesGL_ii": "", "ad6.OperatingExpensesGL_iii": "", "ad6.AnomalyOperatingExpenses": 0, "ad6.OperatingIncomeGL_i": "", "ad6.OperatingIncomeGL_ii": "", "ad6.OperatingIncomeGL_iii": "", "ad6.AnomalyOperatingIncome": 0, "ad6.IncomeBeforeTaxesGL_i": "", "ad6.IncomeBeforeTaxesGL_ii": "", "ad6.IncomeBeforeTaxesGL_iii": "", "ad6.AnomalyIncomeBeforeTaxes": 0, "ad6.NetIncomeGL_i": "", "ad6.NetIncomeGL_ii": "", "ad6.NetIncomeGL_iii": "", "ad6.AnomalyNetIncome": -2394000000, "ad6.OtherComprehensiveIncome": 4765000000, "ad6.ComprehensiveIncome": 0, "ad6.OtherComprehensiveIncomeGL_i": "", "ad6.OtherComprehensiveIncomeGL_ii": "", "ad6.OtherComprehensiveIncomeGL_iii": "", "ad6.AnomalyOtherComprehensiveIncome": 342000000, "ad6.AnomalyComprehensiveIncome": 0, "ad6.ShareholdersEquityBeginning": 0, "ad6.ConvertibleDebt": 0, "ad6.CommonShares": 0, "ad6.PreferredShares": 0, "ad6.RetainedEarnings": 0, "ad6.AccumulatedOtherComprehensiveIncome": 0, "ad6.TreasuryShares": 0, "ad6.EmployeeBenefitTrust": 0, "ad6.NonControllingInterests": 0, "ad6.AnomalyConvertibleDebt": 0, "ad6.AnomalyCommonShares": 0, "ad6.AnomalyPreferredShares": 0, "ad6.AnomalyRetainedEarnings": 0, "ad6.AnomalyAccumulatedOtherComprehensiveIncome": -342000000, "ad6.AnomalyTreasuryShares": 0, "ad6.AnomalyEmployeeBenefitTrust": 0, "ad6.AnomalyNonControllingInterests": 0, "ad6.ShareholdersEquityGL_i": "", "ad6.ShareholdersEquityGL_ii": "", "ad6.ShareholdersEquityGL_iii": "", "ad6.OperatingActivities": 0, "ad6.InvestingActivities": 0, "ad6.FinancingActivities": 0, "ad6.IncreaseDecreaseInCash": 0, "ad6.CashFlowCashExplainedDifference": 0, "ad6.OperatingActivitiesGL_i": "", "ad6.OperatingActivitiesGL_ii": "", "ad6.OperatingActivitiesGL_iii": "", "ad6.AnomalyOperatingActivities": 0, "ad6.AnomalyOperatingActivitiesSEC": 0, "ad6.InvestingActivitiesGL_i": "", "ad6.InvestingActivitiesGL_ii": "", "ad6.InvestingActivitiesGL_iii": "", "ad6.AnomalyInvestingActivities": -2520000000, "ad6.AnomalyInvestingActivitiesSEC": 0, "ad6.FinancingActivitiesGL_i": "", "ad6.FinancingActivitiesGL_ii": "", "ad6.FinancingActivitiesGL_iii": "", "ad6.AnomalyFinancingActivities": -314000000, "ad6.AnomalyFinancingActivitiesSEC": 0, "ad6.TargetWorkingCapital": 1.2, "ad6.ReinvestmentOfMaintenance": 0, "ad6.NormalizedDividendPaymentToNonControllingInterests": 0, "ad6.NormalizedDividendPaymentToPreferredShareholders": 0, "ad6.TheoricalInterestRate": 0.035, "ad6.TheoricalTaxRate": 0.15, "ad6.CapitalizationRateFloor": 0.021, "cf1.AccessionNumber": "0001104659-21-025751", "cf1.AmendmentFlag": "", "cf1.EntityRegistrantName": "ABBOTT LABORATORIES", "cf1.Period": "lastyear", "cf1.PeriodEndDate": "2020-12-31", "cf1.TradingSymbol": "ABT", "cf1.CashBeginningBalance": 3860000000, "cf1.EffectOfExchangeRateOnCash": 71000000, "cf1.DepreciationDepletionAndAmortization": 3327000000, "cf1.GainRelatedToDisposalOrSale": 0, "cf1.RestructuringAndOtherSpecialCharges": 0, "cf1.AccruedEmployeeCompensation": 0, "cf1.ShareBasedCompensation": 546000000, "cf1.IncreaseDecreaseInIncomeTaxExpenseBenefit": -614000000, "cf1.OtherNonCashIncomeExpense": 0, "cf1.IncreaseDecreaseInAccountsReceivable": -924000000, "cf1.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -627000000, "cf1.IncreaseDecreaseInInventories": -493000000, "cf1.IncreaseDecreaseInOtherReceivables": 0, "cf1.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 1766000000, "cf1.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf1.IncreaseDecreaseInRetirementBenefits": 0, "cf1.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf1.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf1.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf1.IncreaseDecreaseInOtherOperatingActivities": 4917500000, "cf1.PaymentsToAcquireInvestments": -2302000000, "cf1.ProceedsOfInvestments": 10000000, "cf1.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf1.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf1.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf1.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf1.ProceedsRelatedToInsuranceSettlement": 0, "cf1.ReveiptOfGovernmentGrants": 0, "cf1.PaymentOfLicenseFee": 0, "cf1.InvestingActivitiesInDiscontinuedOperations": 0, "cf1.OtherInvestingActivities": 77000000, "cf1.FinanceLeasePrincipalPayments": 0, "cf1.ProceedsFromIssuanceOfCommonShares": 0, "cf1.ProceedsFromSharePurchasePlanAndOptionsExercice": 245000000, "cf1.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf1.PaymentsForRepurchaseOfCommonShares": -403000000, "cf1.PaymentsOfDividends": -2560000000, "cf1.IncreaseDecreaseDeferredContingentConsideration": 0, "cf1.ProceedsFromIssuanceOfLongTermDebt": 1281000000, "cf1.RepaymentsOfLongTermDebt": -1333000000, "cf1.FinancingCosts": 0, "cf1.NetChangeInShortTermBorrowings": 2000000, "cf1.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf1.NetChangeInNonControllingInterests": 0, "cf1.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf1.RepaymentsOfConvertible": 0, "cf1.IssuanceOfConvertible": 0, "cf1.EquityInvesteeAdvancesRepayments": 0, "cf1.OtherFinancingActivities": -11000000, "cf1.CashPaidForTaxes": 0, "cf1.CashPaidForInterest": 0, "cf2.AccessionNumber": "0001104659-20-023904", "cf2.AmendmentFlag": "", "cf2.EntityRegistrantName": "ABBOTT LABORATORIES", "cf2.Period": "secondlastyear", "cf2.PeriodEndDate": "2019-12-31", "cf2.TradingSymbol": "ABT", "cf2.CashBeginningBalance": 3844000000, "cf2.EffectOfExchangeRateOnCash": -16000000, "cf2.DepreciationDepletionAndAmortization": 3014000000, "cf2.GainRelatedToDisposalOrSale": 0, "cf2.RestructuringAndOtherSpecialCharges": 63000000, "cf2.AccruedEmployeeCompensation": 0, "cf2.ShareBasedCompensation": 519000000, "cf2.IncreaseDecreaseInIncomeTaxExpenseBenefit": -545000000, "cf2.OtherNonCashIncomeExpense": 0, "cf2.IncreaseDecreaseInAccountsReceivable": -275000000, "cf2.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -138000000, "cf2.IncreaseDecreaseInInventories": -593000000, "cf2.IncreaseDecreaseInOtherReceivables": 0, "cf2.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 220000000, "cf2.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf2.IncreaseDecreaseInRetirementBenefits": 0, "cf2.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf2.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf2.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf2.IncreaseDecreaseInOtherOperatingActivities": 184000000, "cf2.PaymentsToAcquireInvestments": -1911000000, "cf2.ProceedsOfInvestments": 21000000, "cf2.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf2.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf2.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf2.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf2.ProceedsRelatedToInsuranceSettlement": 0, "cf2.ReveiptOfGovernmentGrants": 0, "cf2.PaymentOfLicenseFee": 0, "cf2.InvestingActivitiesInDiscontinuedOperations": 0, "cf2.OtherInvestingActivities": 75000000, "cf2.FinanceLeasePrincipalPayments": 0, "cf2.ProceedsFromIssuanceOfCommonShares": 0, "cf2.ProceedsFromSharePurchasePlanAndOptionsExercice": 298000000, "cf2.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf2.PaymentsForRepurchaseOfCommonShares": -718000000, "cf2.PaymentsOfDividends": -2270000000, "cf2.IncreaseDecreaseDeferredContingentConsideration": 0, "cf2.ProceedsFromIssuanceOfLongTermDebt": 1842000000, "cf2.RepaymentsOfLongTermDebt": -3441000000, "cf2.FinancingCosts": 0, "cf2.NetChangeInShortTermBorrowings": 0, "cf2.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf2.NetChangeInNonControllingInterests": 0, "cf2.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf2.RepaymentsOfConvertible": 0, "cf2.IssuanceOfConvertible": 0, "cf2.EquityInvesteeAdvancesRepayments": 0, "cf2.OtherFinancingActivities": 0, "cf2.CashPaidForTaxes": 0, "cf2.CashPaidForInterest": 0, "cf3.AccessionNumber": "0001047469-19-000624", "cf3.AmendmentFlag": "", "cf3.EntityRegistrantName": "ABBOTT LABORATORIES", "cf3.Period": "thirdlastyear", "cf3.PeriodEndDate": "2018-12-31", "cf3.TradingSymbol": "ABT", "cf3.CashBeginningBalance": 9407000000, "cf3.EffectOfExchangeRateOnCash": -116000000, "cf3.DepreciationDepletionAndAmortization": 3310000000, "cf3.GainRelatedToDisposalOrSale": 0, "cf3.RestructuringAndOtherSpecialCharges": 167000000, "cf3.AccruedEmployeeCompensation": 0, "cf3.ShareBasedCompensation": 477000000, "cf3.IncreaseDecreaseInIncomeTaxExpenseBenefit": -214000000, "cf3.OtherNonCashIncomeExpense": 0, "cf3.IncreaseDecreaseInAccountsReceivable": -190000000, "cf3.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 23000000, "cf3.IncreaseDecreaseInInventories": -514000000, "cf3.IncreaseDecreaseInOtherReceivables": 0, "cf3.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 747000000, "cf3.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf3.IncreaseDecreaseInRetirementBenefits": 0, "cf3.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf3.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf3.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf3.IncreaseDecreaseInOtherOperatingActivities": 126000000, "cf3.PaymentsToAcquireInvestments": -1525000000, "cf3.ProceedsOfInvestments": 73000000, "cf3.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf3.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf3.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf3.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf3.ProceedsRelatedToInsuranceSettlement": 0, "cf3.ReveiptOfGovernmentGrants": 0, "cf3.PaymentOfLicenseFee": 0, "cf3.InvestingActivitiesInDiscontinuedOperations": 0, "cf3.OtherInvestingActivities": 96000000, "cf3.FinanceLeasePrincipalPayments": 0, "cf3.ProceedsFromIssuanceOfCommonShares": 0, "cf3.ProceedsFromSharePurchasePlanAndOptionsExercice": 271000000, "cf3.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf3.PaymentsForRepurchaseOfCommonShares": -238000000, "cf3.PaymentsOfDividends": -1974000000, "cf3.IncreaseDecreaseDeferredContingentConsideration": 0, "cf3.ProceedsFromIssuanceOfLongTermDebt": 4009000000, "cf3.RepaymentsOfLongTermDebt": -12433000000, "cf3.FinancingCosts": 0, "cf3.NetChangeInShortTermBorrowings": -26000000, "cf3.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf3.NetChangeInNonControllingInterests": 0, "cf3.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf3.RepaymentsOfConvertible": 0, "cf3.IssuanceOfConvertible": 0, "cf3.EquityInvesteeAdvancesRepayments": 0, "cf3.OtherFinancingActivities": 0, "cf3.CashPaidForTaxes": 0, "cf3.CashPaidForInterest": 0, "cf4.AccessionNumber": "0001047469-18-000856", "cf4.AmendmentFlag": "", "cf4.EntityRegistrantName": "ABBOTT LABORATORIES", "cf4.Period": "fourthlastyear", "cf4.PeriodEndDate": "2017-12-31", "cf4.TradingSymbol": "ABT", "cf4.CashBeginningBalance": 18620000000, "cf4.EffectOfExchangeRateOnCash": 116000000, "cf4.DepreciationDepletionAndAmortization": 3928000000, "cf4.GainRelatedToDisposalOrSale": -1208000000, "cf4.RestructuringAndOtherSpecialCharges": 0, "cf4.AccruedEmployeeCompensation": 0, "cf4.ShareBasedCompensation": 406000000, "cf4.IncreaseDecreaseInIncomeTaxExpenseBenefit": 1149000000, "cf4.OtherNonCashIncomeExpense": 0, "cf4.IncreaseDecreaseInAccountsReceivable": -207000000, "cf4.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 109000000, "cf4.IncreaseDecreaseInInventories": 249000000, "cf4.IncreaseDecreaseInOtherReceivables": 0, "cf4.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 615000000, "cf4.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf4.IncreaseDecreaseInRetirementBenefits": 0, "cf4.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf4.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf4.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf4.IncreaseDecreaseInOtherOperatingActivities": 52000000, "cf4.PaymentsToAcquireInvestments": -18528000000, "cf4.ProceedsOfInvestments": 129000000, "cf4.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf4.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf4.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf4.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf4.ProceedsRelatedToInsuranceSettlement": 0, "cf4.ReveiptOfGovernmentGrants": 0, "cf4.PaymentOfLicenseFee": 0, "cf4.InvestingActivitiesInDiscontinuedOperations": 0, "cf4.OtherInvestingActivities": 8781000000, "cf4.FinanceLeasePrincipalPayments": 0, "cf4.ProceedsFromIssuanceOfCommonShares": 0, "cf4.ProceedsFromSharePurchasePlanAndOptionsExercice": 350000000, "cf4.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf4.PaymentsForRepurchaseOfCommonShares": -117000000, "cf4.PaymentsOfDividends": -1849000000, "cf4.IncreaseDecreaseDeferredContingentConsideration": -13000000, "cf4.ProceedsFromIssuanceOfLongTermDebt": 6742000000, "cf4.RepaymentsOfLongTermDebt": -8650000000, "cf4.FinancingCosts": 0, "cf4.NetChangeInShortTermBorrowings": -1034000000, "cf4.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf4.NetChangeInNonControllingInterests": 0, "cf4.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf4.RepaymentsOfConvertible": 0, "cf4.IssuanceOfConvertible": 0, "cf4.EquityInvesteeAdvancesRepayments": 0, "cf4.OtherFinancingActivities": -710000000, "cf4.CashPaidForTaxes": 0, "cf4.CashPaidForInterest": 0, "cf5.AccessionNumber": "0001047469-17-000744", "cf5.AmendmentFlag": "", "cf5.EntityRegistrantName": "ABBOTT LABORATORIES", "cf5.Period": "fifthlastyear", "cf5.PeriodEndDate": "2016-12-31", "cf5.TradingSymbol": "ABT", "cf5.CashBeginningBalance": 5001000000, "cf5.EffectOfExchangeRateOnCash": -483000000, "cf5.DepreciationDepletionAndAmortization": 1353000000, "cf5.GainRelatedToDisposalOrSale": -25000000, "cf5.RestructuringAndOtherSpecialCharges": 0, "cf5.AccruedEmployeeCompensation": 0, "cf5.ShareBasedCompensation": 310000000, "cf5.IncreaseDecreaseInIncomeTaxExpenseBenefit": -699000000, "cf5.OtherNonCashIncomeExpense": 0, "cf5.IncreaseDecreaseInAccountsReceivable": -177000000, "cf5.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 113000000, "cf5.IncreaseDecreaseInInventories": -98000000, "cf5.IncreaseDecreaseInOtherReceivables": 0, "cf5.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -652000000, "cf5.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf5.IncreaseDecreaseInRetirementBenefits": 0, "cf5.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf5.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf5.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf5.IncreaseDecreaseInOtherOperatingActivities": 1678000000, "cf5.PaymentsToAcquireInvestments": -4024000000, "cf5.ProceedsOfInvestments": 3709000000, "cf5.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf5.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf5.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf5.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf5.ProceedsRelatedToInsuranceSettlement": 0, "cf5.ReveiptOfGovernmentGrants": 0, "cf5.PaymentOfLicenseFee": 0, "cf5.InvestingActivitiesInDiscontinuedOperations": 0, "cf5.OtherInvestingActivities": 67000000, "cf5.FinanceLeasePrincipalPayments": 0, "cf5.ProceedsFromIssuanceOfCommonShares": 0, "cf5.ProceedsFromSharePurchasePlanAndOptionsExercice": 0, "cf5.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf5.PaymentsForRepurchaseOfCommonShares": -522000000, "cf5.PaymentsOfDividends": -1539000000, "cf5.IncreaseDecreaseDeferredContingentConsideration": -25000000, "cf5.ProceedsFromIssuanceOfLongTermDebt": 14934000000, "cf5.RepaymentsOfLongTermDebt": -12000000, "cf5.FinancingCosts": 0, "cf5.NetChangeInShortTermBorrowings": -1767000000, "cf5.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf5.NetChangeInNonControllingInterests": 0, "cf5.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf5.RepaymentsOfConvertible": 0, "cf5.IssuanceOfConvertible": 0, "cf5.EquityInvesteeAdvancesRepayments": 0, "cf5.OtherFinancingActivities": 78000000, "cf5.CashPaidForTaxes": 0, "cf5.CashPaidForInterest": 0, "cf6.AccessionNumber": "0001047469-16-010246", "cf6.AmendmentFlag": "", "cf6.EntityRegistrantName": "ABBOTT LABORATORIES", "cf6.Period": "sixthlastyear", "cf6.PeriodEndDate": "2015-12-31", "cf6.TradingSymbol": "ABT", "cf6.CashBeginningBalance": 4063000000, "cf6.EffectOfExchangeRateOnCash": -198000000, "cf6.DepreciationDepletionAndAmortization": 1472000000, "cf6.GainRelatedToDisposalOrSale": -3047000000, "cf6.RestructuringAndOtherSpecialCharges": 0, "cf6.AccruedEmployeeCompensation": 0, "cf6.ShareBasedCompensation": 292000000, "cf6.IncreaseDecreaseInIncomeTaxExpenseBenefit": 957000000, "cf6.OtherNonCashIncomeExpense": 0, "cf6.IncreaseDecreaseInAccountsReceivable": -171000000, "cf6.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 57000000, "cf6.IncreaseDecreaseInInventories": -257000000, "cf6.IncreaseDecreaseInOtherReceivables": 0, "cf6.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -742000000, "cf6.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf6.IncreaseDecreaseInRetirementBenefits": 0, "cf6.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf6.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf6.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf6.IncreaseDecreaseInOtherOperatingActivities": -18000000, "cf6.PaymentsToAcquireInvestments": -6278000000, "cf6.ProceedsOfInvestments": 4112000000, "cf6.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf6.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf6.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf6.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf6.ProceedsRelatedToInsuranceSettlement": 0, "cf6.ReveiptOfGovernmentGrants": 0, "cf6.PaymentOfLicenseFee": 0, "cf6.InvestingActivitiesInDiscontinuedOperations": 0, "cf6.OtherInvestingActivities": 2572000000, "cf6.FinanceLeasePrincipalPayments": 0, "cf6.ProceedsFromIssuanceOfCommonShares": 0, "cf6.ProceedsFromSharePurchasePlanAndOptionsExercice": 0, "cf6.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf6.PaymentsForRepurchaseOfCommonShares": -2237000000, "cf6.PaymentsOfDividends": -1443000000, "cf6.IncreaseDecreaseDeferredContingentConsideration": -17000000, "cf6.ProceedsFromIssuanceOfLongTermDebt": 2485000000, "cf6.RepaymentsOfLongTermDebt": -57000000, "cf6.FinancingCosts": 0, "cf6.NetChangeInShortTermBorrowings": -1281000000, "cf6.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf6.NetChangeInNonControllingInterests": 0, "cf6.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf6.RepaymentsOfConvertible": 0, "cf6.IssuanceOfConvertible": 0, "cf6.EquityInvesteeAdvancesRepayments": 0, "cf6.OtherFinancingActivities": 314000000, "cf6.CashPaidForTaxes": 0, "cf6.CashPaidForInterest": 0, "tb1.AccessionNumber": "0001104659-21-025751", "tb1.AmendmentFlag": "", "tb1.EntityRegistrantName": "ABBOTT LABORATORIES", "tb1.Link": "0", "tb1.Period": "lastyear", "tb1.PeriodEndDate": "2020-12-31", "tb1.PeriodOfReport": "0", "tb1.TradingSymbol": "ABT", "tb1.Cash": 6838000000, "tb1.ShortTermInvestments": 310000000, "tb1.AccountsReceivable": 6414000000, "tb1.WorkInProgress": 0, "tb1.Inventories": 5012000000, "tb1.PrepaidExpenses": 0, "tb1.NonTradeReceivables": 0, "tb1.PrepaidTaxAssetsCurrent": 0, "tb1.DeferredTaxAssetsCurrent": 0, "tb1.RightOfUseAssetsCurrent": 0, "tb1.OtherCurrentAssets": 1867000000, "tb1.DiscontinuedOperationsCurrent": 0, "tb1.LongTermReceivables": 0, "tb1.DeferredCharges": 0, "tb1.Investments": 821000000, "tb1.PropertyPlantAndEquipment": 9029000000, "tb1.OperatingLeaseRightOfUseAssets": 0, "tb1.FinanceLeaseRightOfUseAssets": 0, "tb1.IntangibleAssets": 14784000000, "tb1.Goodwill": 23744000000, "tb1.RefundableTaxAssetsNonCurrent": 0, "tb1.DeferredTaxAssetsNonCurrent": 3729000000, "tb1.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.OtherNonCurrentAssets": 0, "tb1.DiscontinuedOperations": 0, "tb1.AccountsPayableAndAccruedLiabilities": -9111000000, "tb1.EmployeeCompensationCurrent": -1416000000, "tb1.OperatingLeasesCurrent": 0, "tb1.FinanceLeasesCurrent": 0, "tb1.DeferredRevenueAndDepositsCurrent": 0, "tb1.AccruedTaxLiabilities": -362000000, "tb1.DeferredTaxLiabilitiesCurrent": 0, "tb1.CommercialPapers": 0, "tb1.ShortTermBorrowings": -213000000, "tb1.OtherCurrentLiabilities": 0, "tb1.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb1.DividendsPayable": -798000000, "tb1.ShortTermPortionOfLongTermDebt": -7000000, "tb1.LongTermDebt": -18527000000, "tb1.PreferredSharesLiability": 0, "tb1.RetirementBenefits": 0, "tb1.OperatingLeasesNonCurrent": 0, "tb1.FinanceLeasesNonCurrent": 0, "tb1.LeaseIncentiveObligation": 0, "tb1.DeferredRevenueAndDepositsNonCurrent": 0, "tb1.ContingentConsideration": 0, "tb1.AccruedTaxLiabilitiesNonCurrent": 0, "tb1.DeferredTaxLiabilitiesNonCurrent": 0, "tb1.OtherNonCurrentLiabilities": -42114000000, "tb1.RedeemableNonControllingInterests": 0, "tb1.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb1.ConvertibleDebtBeginning": 0, "tb1.CommonSharesBeginning": 0, "tb1.CommonSharesIssued": 0, "tb1.ShareBasedCompensation": 0, "tb1.PreferredSharesBeginning": 0, "tb1.RetainedEarningsBeginning": 2500000, "tb1.DividendsAndDividendEquivalentsDeclared": 0, "tb1.CommonSharesRepurchasedAndRetired": 0, "tb1.ShareBasedCompensationRetainedEarnings": 0, "tb1.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb1.RetainedEarningsOthers": 0, "tb1.AccumulatedOtherComprehensiveIncomeBeginning": -150000000, "tb1.TreasurySharesBeginning": 0, "tb1.PurchaseAndSellOfTreasuryShares": 0, "tb1.EmployeeBenefitTrustBeginning": 0, "tb1.NonControllingInterestsBeginning": -219000000, "tb1.DividendsDeclaredToNonControllingInterests": 0, "tb1.AcquisitionOfNonControllingInterests": 0, "tb1.NonControllingInterestsOthers": 0, "tb1.Sales": -34608000000, "tb1.CostOfSales": 15003000000, "tb1.ResearchAndDevelopment": 2420000000, "tb1.SellingGeneralAdministrativeAndMarketing": 11828000000, "tb1.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb1.NonOperatingIncome": 389000000, "tb1.IncomeTaxExpenseBenefit": 0, "tb1.EquityMethodInvesteesIncome": 0, "tb1.NetIncomeFromDiscontinuedOperations": -24000000, "tb1.ChangeInForeignCurrencyTranslationAdjustment": -65000000, "tb1.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 215000000, "tb1.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb1.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.IncomeTaxOnOtherComprehensiveIncome": 0, "tb2.AccessionNumber": "0001104659-20-023904", "tb2.AmendmentFlag": "", "tb2.EntityRegistrantName": "ABBOTT LABORATORIES", "tb2.Link": "0", "tb2.Period": "secondlastyear", "tb2.PeriodEndDate": "2019-12-31", "tb2.PeriodOfReport": "0", "tb2.TradingSymbol": "ABT", "tb2.Cash": 3860000000, "tb2.ShortTermInvestments": 280000000, "tb2.AccountsReceivable": 5425000000, "tb2.WorkInProgress": 0, "tb2.Inventories": 4316000000, "tb2.PrepaidExpenses": 0, "tb2.NonTradeReceivables": 0, "tb2.PrepaidTaxAssetsCurrent": 0, "tb2.DeferredTaxAssetsCurrent": 0, "tb2.RightOfUseAssetsCurrent": 0, "tb2.OtherCurrentAssets": 1786000000, "tb2.DiscontinuedOperationsCurrent": 0, "tb2.LongTermReceivables": 0, "tb2.DeferredCharges": 0, "tb2.Investments": 883000000, "tb2.PropertyPlantAndEquipment": 8038000000, "tb2.OperatingLeaseRightOfUseAssets": 0, "tb2.FinanceLeaseRightOfUseAssets": 0, "tb2.IntangibleAssets": 17025000000, "tb2.Goodwill": 23195000000, "tb2.RefundableTaxAssetsNonCurrent": 0, "tb2.DeferredTaxAssetsNonCurrent": 3079000000, "tb2.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.OtherNonCurrentAssets": 0, "tb2.DiscontinuedOperations": 0, "tb2.AccountsPayableAndAccruedLiabilities": -7287000000, "tb2.EmployeeCompensationCurrent": -1237000000, "tb2.OperatingLeasesCurrent": 0, "tb2.FinanceLeasesCurrent": 0, "tb2.DeferredRevenueAndDepositsCurrent": 0, "tb2.AccruedTaxLiabilities": -226000000, "tb2.DeferredTaxLiabilitiesCurrent": 0, "tb2.CommercialPapers": 0, "tb2.ShortTermBorrowings": -201000000, "tb2.OtherCurrentLiabilities": 0, "tb2.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb2.DividendsPayable": -635000000, "tb2.ShortTermPortionOfLongTermDebt": -1277000000, "tb2.LongTermDebt": -16661000000, "tb2.PreferredSharesLiability": 0, "tb2.RetirementBenefits": 0, "tb2.OperatingLeasesNonCurrent": 0, "tb2.FinanceLeasesNonCurrent": 0, "tb2.LeaseIncentiveObligation": 0, "tb2.DeferredRevenueAndDepositsNonCurrent": 0, "tb2.ContingentConsideration": 0, "tb2.AccruedTaxLiabilitiesNonCurrent": 0, "tb2.DeferredTaxLiabilitiesNonCurrent": 0, "tb2.OtherNonCurrentLiabilities": -40363000000, "tb2.RedeemableNonControllingInterests": 0, "tb2.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb2.ConvertibleDebtBeginning": 0, "tb2.CommonSharesBeginning": 0, "tb2.CommonSharesIssued": 0, "tb2.ShareBasedCompensation": 0, "tb2.PreferredSharesBeginning": 0, "tb2.RetainedEarningsBeginning": 3687000000, "tb2.DividendsAndDividendEquivalentsDeclared": 0, "tb2.CommonSharesRepurchasedAndRetired": 0, "tb2.ShareBasedCompensationRetainedEarnings": 0, "tb2.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb2.RetainedEarningsOthers": 0, "tb2.AccumulatedOtherComprehensiveIncomeBeginning": -4925000000, "tb2.TreasurySharesBeginning": 0, "tb2.PurchaseAndSellOfTreasuryShares": 0, "tb2.EmployeeBenefitTrustBeginning": 0, "tb2.NonControllingInterestsBeginning": -213000000, "tb2.DividendsDeclaredToNonControllingInterests": 0, "tb2.AcquisitionOfNonControllingInterests": 0, "tb2.NonControllingInterestsOthers": 0, "tb2.Sales": -31904000000, "tb2.CostOfSales": 13231000000, "tb2.ResearchAndDevelopment": 2440000000, "tb2.SellingGeneralAdministrativeAndMarketing": 11701000000, "tb2.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb2.NonOperatingIncome": 455000000, "tb2.IncomeTaxExpenseBenefit": 0, "tb2.EquityMethodInvesteesIncome": 0, "tb2.NetIncomeFromDiscontinuedOperations": 0, "tb2.ChangeInForeignCurrencyTranslationAdjustment": 4924000000, "tb2.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 1000000, "tb2.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb2.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.IncomeTaxOnOtherComprehensiveIncome": 0, "tb3.AccessionNumber": "0001047469-19-000624", "tb3.AmendmentFlag": "", "tb3.EntityRegistrantName": "ABBOTT LABORATORIES", "tb3.Link": "0", "tb3.Period": "thirdlastyear", "tb3.PeriodEndDate": "2018-12-31", "tb3.PeriodOfReport": "0", "tb3.TradingSymbol": "ABT", "tb3.Cash": 3844000000, "tb3.ShortTermInvestments": 242000000, "tb3.AccountsReceivable": 5182000000, "tb3.WorkInProgress": 0, "tb3.Inventories": 3796000000, "tb3.PrepaidExpenses": 0, "tb3.NonTradeReceivables": 0, "tb3.PrepaidTaxAssetsCurrent": 0, "tb3.DeferredTaxAssetsCurrent": 0, "tb3.RightOfUseAssetsCurrent": 0, "tb3.OtherCurrentAssets": 1577000000, "tb3.DiscontinuedOperationsCurrent": 0, "tb3.LongTermReceivables": 0, "tb3.DeferredCharges": 0, "tb3.Investments": 897000000, "tb3.PropertyPlantAndEquipment": 7563000000, "tb3.OperatingLeaseRightOfUseAssets": 0, "tb3.FinanceLeaseRightOfUseAssets": 0, "tb3.IntangibleAssets": 18942000000, "tb3.Goodwill": 23254000000, "tb3.RefundableTaxAssetsNonCurrent": 0, "tb3.DeferredTaxAssetsNonCurrent": 1868000000, "tb3.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.OtherNonCurrentAssets": -52507000000, "tb3.DiscontinuedOperations": 0, "tb3.AccountsPayableAndAccruedLiabilities": -6755000000, "tb3.EmployeeCompensationCurrent": -1182000000, "tb3.OperatingLeasesCurrent": 0, "tb3.FinanceLeasesCurrent": 0, "tb3.DeferredRevenueAndDepositsCurrent": 0, "tb3.AccruedTaxLiabilities": -305000000, "tb3.DeferredTaxLiabilitiesCurrent": 0, "tb3.CommercialPapers": 0, "tb3.ShortTermBorrowings": -200000000, "tb3.OtherCurrentLiabilities": 0, "tb3.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb3.DividendsPayable": -563000000, "tb3.ShortTermPortionOfLongTermDebt": -7000000, "tb3.LongTermDebt": -19359000000, "tb3.PreferredSharesLiability": 0, "tb3.RetirementBenefits": 0, "tb3.OperatingLeasesNonCurrent": 0, "tb3.FinanceLeasesNonCurrent": 0, "tb3.LeaseIncentiveObligation": 0, "tb3.DeferredRevenueAndDepositsNonCurrent": 0, "tb3.ContingentConsideration": 0, "tb3.AccruedTaxLiabilitiesNonCurrent": 0, "tb3.DeferredTaxLiabilitiesNonCurrent": -8080000000, "tb3.OtherNonCurrentLiabilities": -30722000000, "tb3.RedeemableNonControllingInterests": 0, "tb3.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb3.ConvertibleDebtBeginning": 0, "tb3.CommonSharesBeginning": 0, "tb3.CommonSharesIssued": 0, "tb3.ShareBasedCompensation": 0, "tb3.PreferredSharesBeginning": 0, "tb3.RetainedEarningsBeginning": 2368000000, "tb3.DividendsAndDividendEquivalentsDeclared": 0, "tb3.CommonSharesRepurchasedAndRetired": 0, "tb3.ShareBasedCompensationRetainedEarnings": 0, "tb3.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb3.RetainedEarningsOthers": 0, "tb3.AccumulatedOtherComprehensiveIncomeBeginning": -4860000000, "tb3.TreasurySharesBeginning": 0, "tb3.PurchaseAndSellOfTreasuryShares": 0, "tb3.EmployeeBenefitTrustBeginning": 0, "tb3.NonControllingInterestsBeginning": -198000000, "tb3.DividendsDeclaredToNonControllingInterests": 0, "tb3.AcquisitionOfNonControllingInterests": 0, "tb3.NonControllingInterestsOthers": 0, "tb3.Sales": -30578000000, "tb3.CostOfSales": 12706000000, "tb3.ResearchAndDevelopment": 2300000000, "tb3.SellingGeneralAdministrativeAndMarketing": 11922000000, "tb3.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb3.NonOperatingIncome": 777000000, "tb3.IncomeTaxExpenseBenefit": 0, "tb3.EquityMethodInvesteesIncome": 0, "tb3.NetIncomeFromDiscontinuedOperations": -68000000, "tb3.ChangeInForeignCurrencyTranslationAdjustment": 4912000000, "tb3.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": -52000000, "tb3.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb3.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.IncomeTaxOnOtherComprehensiveIncome": 0, "tb4.AccessionNumber": "0001047469-18-000856", "tb4.AmendmentFlag": "", "tb4.EntityRegistrantName": "ABBOTT LABORATORIES", "tb4.Link": "0", "tb4.Period": "fourthlastyear", "tb4.PeriodEndDate": "2017-12-31", "tb4.PeriodOfReport": "0", "tb4.TradingSymbol": "ABT", "tb4.Cash": 9407000000, "tb4.ShortTermInvestments": 203000000, "tb4.AccountsReceivable": 5249000000, "tb4.WorkInProgress": 0, "tb4.Inventories": 3601000000, "tb4.PrepaidExpenses": 0, "tb4.NonTradeReceivables": 0, "tb4.PrepaidTaxAssetsCurrent": 0, "tb4.DeferredTaxAssetsCurrent": 0, "tb4.RightOfUseAssetsCurrent": 0, "tb4.OtherCurrentAssets": 1707000000, "tb4.DiscontinuedOperationsCurrent": 0, "tb4.LongTermReceivables": 0, "tb4.DeferredCharges": 0, "tb4.Investments": 883000000, "tb4.PropertyPlantAndEquipment": 7607000000, "tb4.OperatingLeaseRightOfUseAssets": 0, "tb4.FinanceLeaseRightOfUseAssets": 0, "tb4.IntangibleAssets": 21473000000, "tb4.Goodwill": 24020000000, "tb4.RefundableTaxAssetsNonCurrent": 0, "tb4.DeferredTaxAssetsNonCurrent": 1944000000, "tb4.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.OtherNonCurrentAssets": -55751000000, "tb4.DiscontinuedOperations": 0, "tb4.AccountsPayableAndAccruedLiabilities": -6213000000, "tb4.EmployeeCompensationCurrent": -1187000000, "tb4.OperatingLeasesCurrent": 0, "tb4.FinanceLeasesCurrent": 0, "tb4.DeferredRevenueAndDepositsCurrent": 0, "tb4.AccruedTaxLiabilities": -309000000, "tb4.DeferredTaxLiabilitiesCurrent": 0, "tb4.CommercialPapers": 0, "tb4.ShortTermBorrowings": -206000000, "tb4.OtherCurrentLiabilities": 0, "tb4.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb4.DividendsPayable": -489000000, "tb4.ShortTermPortionOfLongTermDebt": -508000000, "tb4.LongTermDebt": -27210000000, "tb4.PreferredSharesLiability": 0, "tb4.RetirementBenefits": 0, "tb4.OperatingLeasesNonCurrent": 0, "tb4.FinanceLeasesNonCurrent": 0, "tb4.LeaseIncentiveObligation": 0, "tb4.DeferredRevenueAndDepositsNonCurrent": 0, "tb4.ContingentConsideration": 0, "tb4.AccruedTaxLiabilitiesNonCurrent": 0, "tb4.DeferredTaxLiabilitiesNonCurrent": 0, "tb4.OtherNonCurrentLiabilities": -40128000000, "tb4.RedeemableNonControllingInterests": 0, "tb4.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb4.ConvertibleDebtBeginning": 0, "tb4.CommonSharesBeginning": 0, "tb4.CommonSharesIssued": 0, "tb4.ShareBasedCompensation": 0, "tb4.PreferredSharesBeginning": 0, "tb4.RetainedEarningsBeginning": 477000000, "tb4.DividendsAndDividendEquivalentsDeclared": 0, "tb4.CommonSharesRepurchasedAndRetired": 0, "tb4.ShareBasedCompensationRetainedEarnings": 0, "tb4.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb4.RetainedEarningsOthers": 0, "tb4.AccumulatedOtherComprehensiveIncomeBeginning": -3536000000, "tb4.TreasurySharesBeginning": 0, "tb4.PurchaseAndSellOfTreasuryShares": 0, "tb4.EmployeeBenefitTrustBeginning": 0, "tb4.NonControllingInterestsBeginning": -201000000, "tb4.DividendsDeclaredToNonControllingInterests": 0, "tb4.AcquisitionOfNonControllingInterests": 0, "tb4.NonControllingInterestsOthers": 0, "tb4.Sales": -27390000000, "tb4.CostOfSales": 12337000000, "tb4.ResearchAndDevelopment": 2235000000, "tb4.SellingGeneralAdministrativeAndMarketing": 11092000000, "tb4.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb4.NonOperatingIncome": -505000000, "tb4.IncomeTaxExpenseBenefit": 0, "tb4.EquityMethodInvesteesIncome": 0, "tb4.NetIncomeFromDiscontinuedOperations": -248000000, "tb4.ChangeInForeignCurrencyTranslationAdjustment": 3452000000, "tb4.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 84000000, "tb4.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb4.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.IncomeTaxOnOtherComprehensiveIncome": 0, "tb5.AccessionNumber": "0001047469-17-000744", "tb5.AmendmentFlag": "", "tb5.EntityRegistrantName": "ABBOTT LABORATORIES", "tb5.Link": "0", "tb5.Period": "fifthlastyear", "tb5.PeriodEndDate": "2016-12-31", "tb5.PeriodOfReport": "0", "tb5.TradingSymbol": "ABT", "tb5.Cash": 18620000000, "tb5.ShortTermInvestments": 155000000, "tb5.AccountsReceivable": 3248000000, "tb5.WorkInProgress": 0, "tb5.Inventories": 2434000000, "tb5.PrepaidExpenses": 0, "tb5.NonTradeReceivables": 0, "tb5.PrepaidTaxAssetsCurrent": 0, "tb5.DeferredTaxAssetsCurrent": 0, "tb5.RightOfUseAssetsCurrent": 0, "tb5.OtherCurrentAssets": 2832000000, "tb5.DiscontinuedOperationsCurrent": 0, "tb5.LongTermReceivables": 0, "tb5.DeferredCharges": 0, "tb5.Investments": 2947000000, "tb5.PropertyPlantAndEquipment": 5705000000, "tb5.OperatingLeaseRightOfUseAssets": 0, "tb5.FinanceLeaseRightOfUseAssets": 0, "tb5.IntangibleAssets": 4539000000, "tb5.Goodwill": 7683000000, "tb5.RefundableTaxAssetsNonCurrent": 0, "tb5.DeferredTaxAssetsNonCurrent": 2263000000, "tb5.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.OtherNonCurrentAssets": -20384000000, "tb5.DiscontinuedOperations": 0, "tb5.AccountsPayableAndAccruedLiabilities": -3759000000, "tb5.EmployeeCompensationCurrent": -752000000, "tb5.OperatingLeasesCurrent": 0, "tb5.FinanceLeasesCurrent": 0, "tb5.DeferredRevenueAndDepositsCurrent": 0, "tb5.AccruedTaxLiabilities": -188000000, "tb5.DeferredTaxLiabilitiesCurrent": 0, "tb5.CommercialPapers": 0, "tb5.ShortTermBorrowings": -1322000000, "tb5.OtherCurrentLiabilities": -490000000, "tb5.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb5.DividendsPayable": -391000000, "tb5.ShortTermPortionOfLongTermDebt": -3000000, "tb5.LongTermDebt": -20681000000, "tb5.PreferredSharesLiability": 0, "tb5.RetirementBenefits": 0, "tb5.OperatingLeasesNonCurrent": 0, "tb5.FinanceLeasesNonCurrent": 0, "tb5.LeaseIncentiveObligation": 0, "tb5.DeferredRevenueAndDepositsNonCurrent": 0, "tb5.ContingentConsideration": 0, "tb5.AccruedTaxLiabilitiesNonCurrent": 0, "tb5.DeferredTaxLiabilitiesNonCurrent": 0, "tb5.OtherNonCurrentLiabilities": 20622000000, "tb5.RedeemableNonControllingInterests": 0, "tb5.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb5.ConvertibleDebtBeginning": 0, "tb5.CommonSharesBeginning": 0, "tb5.CommonSharesIssued": 0, "tb5.ShareBasedCompensation": 0, "tb5.PreferredSharesBeginning": 0, "tb5.RetainedEarningsBeginning": 1400000000, "tb5.DividendsAndDividendEquivalentsDeclared": 0, "tb5.CommonSharesRepurchasedAndRetired": 0, "tb5.ShareBasedCompensationRetainedEarnings": 0, "tb5.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb5.RetainedEarningsOthers": 0, "tb5.AccumulatedOtherComprehensiveIncomeBeginning": -4910000000, "tb5.TreasurySharesBeginning": 0, "tb5.PurchaseAndSellOfTreasuryShares": 0, "tb5.EmployeeBenefitTrustBeginning": 0, "tb5.NonControllingInterestsBeginning": -179000000, "tb5.DividendsDeclaredToNonControllingInterests": 0, "tb5.AcquisitionOfNonControllingInterests": 0, "tb5.NonControllingInterestsOthers": 0, "tb5.Sales": -20853000000, "tb5.CostOfSales": 9024000000, "tb5.ResearchAndDevelopment": 1422000000, "tb5.SellingGeneralAdministrativeAndMarketing": 7222000000, "tb5.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb5.NonOperatingIncome": 1772000000, "tb5.IncomeTaxExpenseBenefit": 0, "tb5.EquityMethodInvesteesIncome": 0, "tb5.NetIncomeFromDiscontinuedOperations": -674000000, "tb5.ChangeInForeignCurrencyTranslationAdjustment": 4959000000, "tb5.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": -49000000, "tb5.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb5.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.IncomeTaxOnOtherComprehensiveIncome": 0, "tb6.AccessionNumber": "0001047469-16-010246", "tb6.AmendmentFlag": "", "tb6.EntityRegistrantName": "ABBOTT LABORATORIES", "tb6.Link": "0", "tb6.Period": "sixthlastyear", "tb6.PeriodEndDate": "2015-12-31", "tb6.PeriodOfReport": "0", "tb6.TradingSymbol": "ABT", "tb6.Cash": 5001000000, "tb6.ShortTermInvestments": 1124000000, "tb6.AccountsReceivable": 3418000000, "tb6.WorkInProgress": 0, "tb6.Inventories": 2599000000, "tb6.PrepaidExpenses": 0, "tb6.NonTradeReceivables": 0, "tb6.PrepaidTaxAssetsCurrent": 0, "tb6.DeferredTaxAssetsCurrent": 0, "tb6.RightOfUseAssetsCurrent": 0, "tb6.OtherCurrentAssets": 2118000000, "tb6.DiscontinuedOperationsCurrent": 0, "tb6.LongTermReceivables": 0, "tb6.DeferredCharges": 0, "tb6.Investments": 4041000000, "tb6.PropertyPlantAndEquipment": 5730000000, "tb6.OperatingLeaseRightOfUseAssets": 0, "tb6.FinanceLeaseRightOfUseAssets": 0, "tb6.IntangibleAssets": 5562000000, "tb6.Goodwill": 9638000000, "tb6.RefundableTaxAssetsNonCurrent": 0, "tb6.DeferredTaxAssetsNonCurrent": 2119000000, "tb6.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.OtherNonCurrentAssets": -27088000000, "tb6.DiscontinuedOperations": 0, "tb6.AccountsPayableAndAccruedLiabilities": -4124000000, "tb6.EmployeeCompensationCurrent": -746000000, "tb6.OperatingLeasesCurrent": 0, "tb6.FinanceLeasesCurrent": 0, "tb6.DeferredRevenueAndDepositsCurrent": 0, "tb6.AccruedTaxLiabilities": -430000000, "tb6.DeferredTaxLiabilitiesCurrent": 0, "tb6.CommercialPapers": 0, "tb6.ShortTermBorrowings": -3127000000, "tb6.OtherCurrentLiabilities": -746000000, "tb6.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb6.DividendsPayable": -383000000, "tb6.ShortTermPortionOfLongTermDebt": -3000000, "tb6.LongTermDebt": -5871000000, "tb6.PreferredSharesLiability": 0, "tb6.RetirementBenefits": 0, "tb6.OperatingLeasesNonCurrent": 0, "tb6.FinanceLeasesNonCurrent": 0, "tb6.LeaseIncentiveObligation": 0, "tb6.DeferredRevenueAndDepositsNonCurrent": 0, "tb6.ContingentConsideration": 0, "tb6.AccruedTaxLiabilitiesNonCurrent": 0, "tb6.DeferredTaxLiabilitiesNonCurrent": -4864000000, "tb6.OtherNonCurrentLiabilities": -20953000000, "tb6.RedeemableNonControllingInterests": 0, "tb6.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb6.ConvertibleDebtBeginning": 0, "tb6.CommonSharesBeginning": 0, "tb6.CommonSharesIssued": 0, "tb6.ShareBasedCompensation": 0, "tb6.PreferredSharesBeginning": 0, "tb6.RetainedEarningsBeginning": 4423000000, "tb6.DividendsAndDividendEquivalentsDeclared": 0, "tb6.CommonSharesRepurchasedAndRetired": 0, "tb6.ShareBasedCompensationRetainedEarnings": 0, "tb6.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb6.RetainedEarningsOthers": 0, "tb6.AccumulatedOtherComprehensiveIncomeBeginning": -4765000000, "tb6.TreasurySharesBeginning": 0, "tb6.PurchaseAndSellOfTreasuryShares": 0, "tb6.EmployeeBenefitTrustBeginning": 0, "tb6.NonControllingInterestsBeginning": -115000000, "tb6.DividendsDeclaredToNonControllingInterests": 0, "tb6.AcquisitionOfNonControllingInterests": 0, "tb6.NonControllingInterestsOthers": 0, "tb6.Sales": -20405000000, "tb6.CostOfSales": 8747000000, "tb6.ResearchAndDevelopment": 1405000000, "tb6.SellingGeneralAdministrativeAndMarketing": 7386000000, "tb6.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb6.NonOperatingIncome": -316000000, "tb6.IncomeTaxExpenseBenefit": 0, "tb6.EquityMethodInvesteesIncome": 0, "tb6.NetIncomeFromDiscontinuedOperations": -3634000000, "tb6.ChangeInForeignCurrencyTranslationAdjustment": 4829000000, "tb6.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": -64000000, "tb6.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb6.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.IncomeTaxOnOtherComprehensiveIncome": 0}]}